Young Diane C.'s Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Aug 19, 2022
- Accession no.
- 0001415889-22-008895
- Filed
- Aug 19, 2022
- Trade date
- Aug 17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $708.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young Diane C.CIK 0001648010 | Officer (SVP, CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | MOption exerciseAcquired | +19,000 | $10.38 | +$197,220 | 21,115 | Direct | |
| Aug 17, 2022 | Common Stock | SSaleDisposed | −19,000 | $37.30 | −$708,700 | 2,115 | Direct | |
| Aug 17, 2022 | Common Stock | MOption exerciseAcquired | +45,000 | $2.71 | +$121,950 | 47,115 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | MOption exerciseDisposed | −19,000 | $0.00 | $0 | 48,400 | Direct | |
| Aug 17, 2022 | Common Stock | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 15,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.